Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

v3.23.1
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2021 $ 42 $ 458,046 $ (1,784) $ (242,470) $ 213,834
Balance, shares at Dec. 31, 2021 42,423,514        
Common stock issued upon exercises of warrants 69 69
Common stock issued upon exercises of warrants, shares 16,811        
Stock-based compensation $ 1 1,932 1,933
Stock-based compensation, shares 144,497        
Other comprehensive loss (606) (606)
Net loss (15,143) (15,143)
Balance at Mar. 31, 2022 $ 43 460,047 (2,390) (257,613) 200,087
Balance, shares at Mar. 31, 2022 42,584,822        
Balance at Dec. 31, 2022 $ 51 597,982 (3,046) (334,030) 260,957
Balance, shares at Dec. 31, 2022 51,476,445        
Common stock issued in public offering, net of issuance costs [1] $ 8 94,758 94,766
Common stock issued in public offering, net of issuance costs, shares [1] 8,333,333        
Common stock issued upon exercises of warrants $ 1 834 835
Common stock issued upon exercises of warrants, shares 557,733        
Stock-based compensation 7,757 7,757
Stock-based compensation, shares 5,866        
Other comprehensive loss (850) (850)
Net loss (29,801) (29,801)
Balance at Mar. 31, 2023 $ 60 $ 701,331 $ (3,896) $ (363,831) $ 333,664
Balance, shares at Mar. 31, 2023 60,373,377        
[1] Includes gross proceeds of $100,000, less issuance costs of $5,234.